Sanofi

Clinical study results Vaccines

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

408 result(s) found
Generic NameTrade NameCondition(s)Study CodeAccess to Study / ProtocolAccess to Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L24NCT01177722Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L26NCT01105559Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L27NCT01444781Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L28NCT01983540Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L31NCT02094833Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L33NCT01948193Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L35NCT02428491
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim®/Hexacima®/Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L35NCT02428491Tabulated Results Posted
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L38EudraCT 2012-001054-26Tabulated Results
DTAP-IPV- HEP B-HIB VACCINE
Hexaxim® Hexacima® Hexyon®
Diphtheria; Tetanus; Pertussis; Haemophilus Influenzae Type b; Poliomyelitis; Hepatitis B
A3L39EudraCT: 2012-001055-39Tabulated Results